101-105
FINALPhiladelphia
76ers
43-45|L10: 3-7
Denver
Nuggets
64-34|L10: 5-5
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
Denver Nuggets
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 66-16 | 0.805 |
| Opponent | Date | Result |
|---|---|---|
| 12/23 | L 91-110 | |
| 12/20 |
| — |
| 2 | 62-20 | 0.756 | 4.0 |
| 3 | 59-23 | 0.720 | 7.0 |
| 4 | 47-35 | 0.573 | 19.0 |
| 5 | 43-39 | 0.524 | 23.0 |
| 6 | 41-41 | 0.500 | 25.0 |
| 7 | 41-41 | 0.500 | 25.0 |
| 8 | 115-124 | 0.481 | 29.5 |
| 9 | 39-43 | 0.476 | 27.0 |
| 10 | 36-46 | 0.439 | 30.0 |
| 11 | 33-48 | 0.407 | 32.5 |
| 12 | 33-49 | 0.402 | 33.0 |
| 13 | 32-49 | 0.395 | 33.5 |
| 14 | 19-63 | 0.232 | 47.0 |
| 15 | 0-0 | 0.000 | 25.0 |
| 12/19 | W 109-103 |
| 12/17 | W 93-88 |
| 12/13 | W 104-89 |
| Opponent | Date | Result |
|---|---|---|
| 12/23 | L 92-101 | |
| 12/22 | W 97-89 | |
| 12/20 | L 101-108 | |
| 12/19 | L 88-105 | |
| 12/16 | L 96-108 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 19.0 | 46.4% | 26.9% | 67.5% | |
| 16.6 | 48.2% | 14.8% | 77.9% | |
| 15.0 | 48.7% | 28.5% | 53.2% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 23.6 |
| 44.0% |
| 30.2% |
| 73.2% |
| 18.7 | 43.7% | 17.8% | 73.6% |
| 18.3 | 42.2% | 40.6% | 84.1% |
| Category | DEN Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #588.6 ORtg | #11105.5 DRtg | DEN |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #2212.3% | #316.0% | DEN |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #1136.8% | #835.7% | PHI |
| Category | DEN Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #8104.8 DRtg | #2283.5 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #815.0% | #1311.5% | DEN |
3P% vs AllowedPerimeter defense vs perimeter shooting | #1236.1% | #2832.9% | PHI |
